FDA IND Clearance

Marker Therapeutics Shares Jump 60 Percent As FDA Announced Clearance To Blood Cell Cancer Study

Eledon Secures FDA Clearance For Kidney Transplant Rejection Study

HOOKIPA Gets FDA Nod For Initial-Stage Prostate Cancer Study

Eledon Secures FDA Clearance For Kidney Transplant Rejection Study

HOOKIPA Gets FDA Nod For Initial-Stage Prostate Cancer Study

Sorrento Shares Gain Following FDA's Nod for Initial-Stage Covid-19 Study

NexImmune Shares Soar Following FDA's Clearance To Initial-Stage HPV Cancer Study

Sorrento Shares Gain Following FDA's Nod for Initial-Stage Covid-19 Study

NexImmune Shares Soar Following FDA's Clearance To Initial-Stage HPV Cancer Study

Omega Therapeutics Gets FDA Nod For Initial-Stage Liver Cancer Study

Titan Pharmaceuticals Gets FDA Clearance To Commence Opioid Disorder Study

FDA IND Clearance Recent News

Schrödinger's Initial-Stage Cancer Study Gains FDA Clearance

Schrödinger Inc. (NASDAQ: SDGR) announced that the U.S. Food and Drug Administration (FDA) cleared its investigational new drug (IND) application for the drug candidate SGR-1505 in patients with relapsed or refractory B-cell lymphoma.

Soligenix Gets FDA Nod For Mid-Stage Psoriasis Study

The U.S. Food and Drug Administration (FDA) has cleared Soligenix’s (NASDAQ: SNGX) Investigational New Drug (IND) application for Phase 2a clinical trial Evaluating SGX302 in the treatment of patients with Mild-to-Moderate Psoriasis.

Nuvectis Pharma Gets FDA Nod For Initial-Stage Ovarian Cancer Study

The U.S. Food and Drug Administration (FDA) cleared Nuvectis Pharma’s (NASDAQ: NVCT) Investigational New Drug Application (IND) for NXP800, which includes the Phase 1 clinical trial protocol.